Impact of rilpivirine cross-resistance on long-acting cabotegravir-rilpivirine in low and middle-income countries. Steegen K, Chandiwana N, Sokhela S, Venter WDF, et al. AIDS 2023;37:1009-1011.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Steegen K, Chandiwana N, Sokhela S, Venter WDF, et al. Impact of rilpivirine cross-resistance on long-acting cabotegravir-rilpivirine in low and middle-income countries. AIDS 2023;37:1009-1011.
PMID: 36779485